ArticleBMC gastroenterology2025
Association of pleural effusion on thoracic ultrasound with severe acute pancreatitis and mortality.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Validation of an Early Severity Prediction Model for Hypertriglyceridemia-Associated Acute Pancreatitis: A Multicenter Cohort Study.Journal of inflammation research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute pancreatitis (AP) is an inflammatory condition associated with significant morbidity and mortality that often leads to thoracic complications. Timely identification of these complications, including pleural effusion (PE), is of utmost importance because it may indicate AP severity.
methodsThis prospective cohort aimed to determine the association between the presence of PE and other lung findings identified by thoracic ultrasound (TUS) and AP severity. We included patients diagnosed with AP according to the Atlanta classification. TUS was performed within the first 48 h of diagnosis, six quadrants per hemithorax were examined to assess the presence of PE and different pulmonary patterns. AP severity scales were applied, and mortality was calculated based on the presence or absence of PE or other lung findings.
resultsWe included 107 patients with AP with a mean age of 37 (28-51) years, 66 (62%) females. TUS identified PE in 20.5% of the cases. The Atlanta classification system revealed a higher proportion of severe AP among the patients with PE (40.9% vs. 2.4%, p < 0.001). Also, patients with PE showed a higher Marshall (2 ± 2.13 vs. 1.12 ± 1.17, p = 0.0295) and APACHE II scores (8.36 ± 5.34 vs. 5.52 ± 3.62, p = 0.022). PE and Marshall score were independent factors associated with higher mortality in a multivariate model, with odds ratios of 6.89 (1.18-50.49) and 3.00 (1.42-7.90), respectively.
conclusionsEarly detection of PE using TUS in patients with AP is strongly associated with disease severity and mortality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.